中国医药：阿司匹林肠溶片获得药品补充申请批准通知书

Group 1 - The core point of the article is that China Medical (600056.SH) announced that its wholly-owned subsidiary Tianfang Pharmaceutical has received approval from the National Medical Products Administration for the supplement application of enteric-coated aspirin tablets, which have passed the consistency evaluation of quality and efficacy for generic drugs [1] - The enteric-coated aspirin tablets are primarily used for the treatment of unstable angina, acute myocardial infarction, prevention of recurrent myocardial infarction, post-arterial vascular surgery or interventional surgery, prevention of transient ischemic attacks, and prevention of cerebral infarction after early symptoms have appeared [1]